Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 679
117th Congress(2021-2022)
Effective Drug Control Strategy Act of 2021
Introduced
Introduced
Introduced in House on Feb 1, 2021
Overview
Text
Introduced in House 
Feb 1, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Feb 1, 2021)
Feb 1, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 679 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 679


To amend the Office of National Drug Control Policy Reauthorization Act of 1998 to direct the Office of National Drug Control Policy to publish a list of drug control grant programs, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

February 1, 2021

Mr. Trone (for himself and Mr. Burchett) introduced the following bill; which was referred to the Committee on Oversight and Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Office of National Drug Control Policy Reauthorization Act of 1998 to direct the Office of National Drug Control Policy to publish a list of drug control grant programs, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Effective Drug Control Strategy Act of 2021”.

SEC. 2. Federal drug demand reduction activities.

(a) Publication of list.—

(1) AMENDMENT.—Section 705(f) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1704(f)) is amended by inserting at the end the following new paragraph:

“(5) PUBLICATION OF LIST.—The Director shall publish online a complete list of all drug control program grant programs and any other relevant information included in the information tracked pursuant to paragraph (1).”.

(2) DEADLINE AND FREQUENCY.—Not later than one year after the date of the enactment of this Act, and annually thereafter, the Director of National Drug Control Policy shall publish the list required under section 705(f)(5) of the National Drug Control Act of 1998, as added by paragraph (1).

(b) National Drug Control Strategy.—Section 706(c)(1) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1705(c)(1)) is amended by adding at the end the following new subparagraph:

“(O) A review of all federally funded demand reduction activities, including an evaluation of—

“(i) the effectiveness of those activities;

“(ii) the contribution of those activities to demand reduction activities funded by State, local, and Tribal governments; and

“(iii) whether any duplication or inefficiency in federally funded demand reduction activities needs to be addressed.”.